Fastidious intracellular bacteria as causal agents of community-acquired pneumonia.

作者: Frédéric Lamoth , Gilbert Greub

DOI: 10.1586/ERI.10.52

关键词:

摘要: Intracellular bacteria are common causes of community-acquired pneumonia that grow poorly or not at all on standard culture media and do respond to beta-lactam antibiotic therapy. Apart from well-established agents such as Legionella pneumophila, Mycoplasma pneumoniae, Chlamydia psittaci Coxiella burnetii, some new emerging pathogens have recently been recognized, mainly Parachlamydia acanthamoebae Simkania negevensis, two Chlamydia-related bacteria. Most them benign self-limited infections. However, they may cause severe in cases (i.e., Legionnaires' disease) outbreaks representing a public health problem deserving prompt recognition appropriate Although extrapulmonary manifestations often present, no clinical features allow be distinguished classical bacterial Streptococcus pneumoniae. Thus, specific molecular diagnostic tools very helpful for early the offending bacteria, whereas serology only allows retrospective late diagnosis. Macrolides remain best empirical treatment intracellular respiratory pathogens, although observational studies suggest quinolones superior legionellosis.

参考文章(204)
Nicholas D. Walter, Gavin B. Grant, Utpala Bandy, Nicole E. Alexander, Jonas M. Winchell, Hannah T. Jordan, James J. Sejvar, Lauri A. Hicks, David R. Gifford, Nicole T. Alexander, Kathleen A. Thurman, Stephanie B. Schwartz, Penelope H. Dennehy, Nino Khetsuriani, Barry S. Fields, Michael T. Dillon, Dean D. Erdman, Cynthia G. Whitney, Matthew R. Moore, Community Outbreak of Mycoplasma pneumoniae Infection: School-Based Cluster of Neurologic Disease Associated with Household Transmission of Respiratory Illness The Journal of Infectious Diseases. ,vol. 198, pp. 1365- 1374 ,(2008) , 10.1086/592281
Núria Fernández-Sabé, Beatriz Rosón, Jordi Carratalà, Jordi Dorca, Frederic Manresa, Francesc Gudiol, Clinical Diagnosis of Legionella Pneumonia Revisited: Evaluation of the Community-Based Pneumonia Incidence Study Group Scoring System Clinical Infectious Diseases. ,vol. 37, pp. 483- 489 ,(2003) , 10.1086/376627
Aldona L. Baltch, Lawrence H. Bopp, Raymond P. Smith, Phyllis B. Michelsen, William J. Ritz, Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes Journal of Antimicrobial Chemotherapy. ,vol. 56, pp. 104- 109 ,(2005) , 10.1093/JAC/DKI186
Rosanna W. Peeling, Jens Boman, George M. Carlone, Barry S. Fields, Jeannette Guarner, Margaret R. Hammerschlag, Lisa A. Jackson, Cho‐Chou Kuo, Matthias Maass, Trudy O. Messmer, Deborah F. Talkington, Maria Lucia Tondella, Sherif R. Zaki, , Scott F. Dowell, Standardizing Chlamydia pneumoniae assays : Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada) Clinical Infectious Diseases. ,vol. 33, pp. 492- 503 ,(2001) , 10.1086/322632
Victor L. Yu, Richard N. Greenberg, Neringa Zadeikis, Janet E. Stout, Mohammed M. Khashab, William H. Olson, Alan M. Tennenberg, Levofloxacin Efficacy in the Treatment of Community-Acquired Legionellosis Chest. ,vol. 125, pp. 2135- 2139 ,(2004) , 10.1378/CHEST.125.6.2135
A. Mykietiuk, J. Carratala, N. Fernandez-Sabe, J. Dorca, R. Verdaguer, F. Manresa, F. Gudiol, Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy Clinical Infectious Diseases. ,vol. 40, pp. 794- 799 ,(2005) , 10.1086/428059
M. Woodhead, Community-acquired pneumonia in Europe: causative pathogens and resistance patterns European Respiratory Journal. ,vol. 20, pp. 20S- 27s ,(2002) , 10.1183/09031936.02.00702002
David R. Murdoch, Diagnosis of Legionella Infection Clinical Infectious Diseases. ,vol. 36, pp. 64- 69 ,(2003) , 10.1086/345529
GEORGES DUPUIS, JACQUES PETITE, OLIVIER PÉTER, MICHEL VOUILLOZ, An Important Outbreak of Human Q Fever in a Swiss Alpine Valley International Journal of Epidemiology. ,vol. 16, pp. 282- 287 ,(1987) , 10.1093/IJE/16.2.282
Thomas M File Jr, Lionel A Mandell, Glenn Tillotson, Kosta Kostov, Ognian Georgiev, None, Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study Journal of Antimicrobial Chemotherapy. ,vol. 60, pp. 112- 120 ,(2007) , 10.1093/JAC/DKM119